Novartis AG Total Long Term Liabilities 2010-2024 | NVS

Novartis AG total long term liabilities for the quarter ending September 30, 2024 were $31.951B, a 22.61% increase year-over-year.

  • Novartis AG total long term liabilities for 2023 were $26.805B, a 8.75% decline from 2022.
  • Novartis AG total long term liabilities for 2022 were $29.374B, a 13% decline from 2021.
  • Novartis AG total long term liabilities for 2021 were $33.765B, a 11.27% decline from 2020.

Novartis AG Total Long Term Liabilities 2010-2024 | NVS

  • Novartis AG total long term liabilities for 2023 were $26.805B, a 8.75% decline from 2022.
  • Novartis AG total long term liabilities for 2022 were $29.374B, a 13% decline from 2021.
  • Novartis AG total long term liabilities for 2021 were $33.765B, a 11.27% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B